| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |